Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBSSL for Fat Absorption in Cystic Fibrosis
NCT00743483Phase 2Completed
- Sponsor
- Sobi
- Start
- Aug 2008
- Primary completion
- Jun 2009
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of bucelipase alfa in exocrine pancreatic insufficiency (EPI), sponsored by Sobi. Started Aug 2008; status: completed.
02
Drugs
bucelipase alfa
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00743483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743483.